| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Silence Therapeutics plc | Director | Share Option (Right to Buy) | 90,000 | 02 Jan 2026 | Direct | ||
| Silence Therapeutics plc | Director | Ordinary Shares | 15,000 | 14 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SLN | Silence Therapeutics plc | 02 Jan 2026 | 1 | $0 | 4 | Director | 06 Jan 2026, 16:15 |
| SLN | Silence Therapeutics plc | 22 Dec 2025 | 1 | $0 | 4 | Director | 22 Dec 2025, 18:03 |
| SLN | Silence Therapeutics plc | 14 Dec 2025 | 0 | $0 | 3 | Director | 22 Dec 2025, 18:02 |
| SLN | Silence Therapeutics plc | 02 Jan 2025 | 1 | $0 | 4 | Director | 06 Jan 2025, 16:15 |
| SLN | Silence Therapeutics plc | 02 Jan 2025 | 0 | $0 | 3 | Director | 02 Jan 2025, 16:36 |